Next-Generation Sequencing and Proviral DNA: The Future of HIV Drug Resistance Testing?

Chanson Brumme, PhD
Assistant Director, BC-CfE Research Laboratories
Assistant Professor, UBC Division of Infectious Diseases

Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025